Clinical Trial Update: Androgen Regulation of Priapism in Sickle Cell Disease [EARLY_Phase 1]

View source ↗

Summary

This document announces the withdrawal of an early-phase trial investigating androgen regulation of priapism in sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Priapism
• Sickle Cell Disease

Snippet

Sponsor: Johns Hopkins University | Conditions: Priapism, Sickle Cell Disease | EARLY_Phase 1 | Status: WITHDRAWN